STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Communication Services Entertainment
investing

Wall Street’s Top Research Upgrades: Lyft, EA, Exelixis, Broadcom, MakeMyTrip

byLuca Blaumann
June 24, 2025
in Entertainment, Large-Cap, Semiconductors
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Analysts highlight best ideas for 2025 with bullish calls on growth, innovation, and market resilience

Wall Street analysts are rolling out fresh bullish calls on several stocks, with five notable upgrades making waves in today’s market, according to a roundup by The Fly. These research calls span sectors from ride-hailing and gaming to biotech and semiconductors—each backed by a clear growth narrative and increased analyst conviction.

Lyft (LYFT) led the list after TD Cowen upgraded the stock to Buy from Hold and raised its price target to $21 from $16. TD Cowen named Lyft its “Best Smidcap Idea” for 2025, citing growth levers including expansion outside the top 25 U.S. markets, international growth through its FREENOW acquisition, and product innovations such as price lock.

Electronic Arts (EA) received an upgrade from Roth Capital to Buy from Neutral, with a higher price target of $185 (up from $175). The firm sees increased confidence in EA’s ability to deliver consistent double-digit earnings growth over the next three years, driven by strong execution and a healthy game pipeline.

Exelixis (EXEL) saw one of the most dramatic target increases—from $29 to $60—as Stephens upgraded the biotech name to Overweight from Equal Weight. Calling it the firm’s “Best Idea,” the analyst believes Cabometyx can maintain market share in renal cell carcinoma (RCC), even amid competitive trial data.

Broadcom (AVGO) was upgraded to Buy from Hold by HSBC, with a $400 price target, reinforcing optimism around its AI-driven semiconductor demand and strategic acquisitions.

MakeMyTrip (MMYT) also earned an Outperform rating from Macquarie, which highlighted the company’s $3.1 billion capital raise as a key growth catalyst.

These upgrades reflect growing analyst confidence in companies with clear expansion paths, strong balance sheets, and innovative strategies for long-term growth.

You might like this article:Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast

Tags: AGROAVGOEAExelixisGrowthLyftMoversNewsStock Market
Previous Post

Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast

Next Post

Nektar Therapeutics Surges After Positive Eczema Drug Trial Results

Related Posts

chemistry-2

Nektar Therapeutics Surges After Positive Eczema Drug Trial Results

byLuca Blaumann
June 24, 2025
0

Shares double as midstage study shows promising efficacy and safety for autoimmune treatment Nektar Therapeutics (NKTR) saw its shares double...

investing

Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast

byLuca Blaumann
June 24, 2025
0

Robust travel demand and onboard spending push Carnival Corp to raise full-year profit outlook Carnival Corp (CCL) raised its annual...

Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter

byLiliana Vida
June 20, 2025
0

Grocery giant raises same-store sales outlook while navigating leadership uncertainty and a tough retail landscape Kroger (KR) stock jumped 9%...

Next Post
chemistry-2

Nektar Therapeutics Surges After Positive Eczema Drug Trial Results

Latest News

Nektar Therapeutics Surges After Positive Eczema Drug Trial Results

Wall Street’s Top Research Upgrades: Lyft, EA, Exelixis, Broadcom, MakeMyTrip

Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast

Tesla Keeps Robotaxi Safety Details Confidential Amid Federal Review

Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter

Based on Your Interest

Large-Cap

Intel Hires Top Industry Talent to Bolster Engineering and AI Teams

June 18, 2025
Pharmaceuticals

MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog

June 18, 2025
investing
Large-Cap

AMD’s Growth Engine Accelerates as Piper Sandler Raises Price Target to $140

June 16, 2025

Recommended

Mega-Cap

Strategy Doubles Down on Bitcoin with $1.05B Buy Despite Market Jitters

June 16, 2025
Asset Management

Lloyd Financial CEO & CIO Sees Golden Opportunity in Treasuries and Utilities Amid AI-Driven Deflation

June 13, 2025
Aerospace & Defense

Defense Stocks Rally as Middle East Tensions Escalate Following Israeli Airstrikes

June 13, 2025
Semiconductors

Oracle Soars on Cloud Optimism and AI Momentum

June 12, 2025
Large-Cap

Micron to Invest $30 Billion More in U.S. Semiconductor Expansion

June 12, 2025
Stoxpo

Follow us on social media:

Highlights

  • Nektar Therapeutics Surges After Positive Eczema Drug Trial Results
  • Wall Street’s Top Research Upgrades: Lyft, EA, Exelixis, Broadcom, MakeMyTrip
  • Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast
  • Tesla Keeps Robotaxi Safety Details Confidential Amid Federal Review
  • Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

chemistry-2

Nektar Therapeutics Surges After Positive Eczema Drug Trial Results

June 24, 2025
investing

Wall Street’s Top Research Upgrades: Lyft, EA, Exelixis, Broadcom, MakeMyTrip

June 24, 2025
investing

Carnival Cruises Past Expectations with Strong Q2 Results and Upbeat Forecast

June 24, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?